Gerresheimer (ETR:GXI) has been given a €81.00 ($94.19) price target by stock analysts at Berenberg Bank in a report issued on Tuesday. The brokerage currently has a “buy” rating on the stock. Berenberg Bank’s target price would indicate a potential upside of 13.29% from the company’s previous close.

A number of other analysts have also issued reports on the stock. Commerzbank set a €68.00 ($79.07) price objective on shares of Gerresheimer and gave the company a “neutral” rating in a research note on Wednesday, August 29th. Hauck & Aufhaeuser set a €60.00 ($69.77) price objective on shares of Gerresheimer and gave the company a “sell” rating in a research note on Wednesday, September 5th. DZ Bank reiterated a “buy” rating on shares of Gerresheimer in a research note on Monday, May 28th. HSBC set a €67.00 ($77.91) price objective on shares of Gerresheimer and gave the company a “neutral” rating in a research note on Friday, June 1st. Finally, JPMorgan Chase & Co. set a €79.40 ($92.33) price objective on shares of Gerresheimer and gave the company a “neutral” rating in a research note on Friday, July 6th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the stock. Gerresheimer presently has an average rating of “Hold” and a consensus price target of €72.50 ($84.30).

GXI opened at €71.50 ($83.14) on Tuesday. Gerresheimer has a 52-week low of €59.97 ($69.73) and a 52-week high of €78.25 ($90.99).

About Gerresheimer

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Further Reading: Marijuana Stocks

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.